Morgan Stanley Gritstone Bio, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 10,295,665 shares of GRTS stock, worth $308,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,295,665

Previous 4,454,027 131.15%

Holding current value

$308,869

Previous $2.76 Million 116.26%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.45 - $0.71 $2.63 Million - $4.15 Million	5,841,638 Added 131.15%	10,295,665 $5.97 Million
Q2 2024 Oct 17, 2024	SELL	$0.62 - $2.35 $1.42 Million - $5.38 Million	-2,287,863 Reduced 33.94%	4,454,027 $2.76 Million
Q2 2024 Aug 14, 2024	SELL	$0.62 - $2.35 $1.42 Million - $5.38 Million	-2,287,863 Reduced 33.94%	4,454,027 $2.76 Million
Q1 2024 Oct 17, 2024	BUY	$1.96 - $2.9 $4.48 Million - $6.63 Million	2,287,863 Added 51.37%	6,741,890 $17.3 Million
Q1 2024 Aug 16, 2024	BUY	$1.96 - $2.9 $2.39 Million - $3.54 Million	1,221,437 Added 22.13%	6,741,890 $17.3 Million
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $2.39 Million - $3.54 Million	1,221,437 Added 22.13%	6,741,890 $17.3 Million
Q4 2023 Aug 16, 2024	BUY	$1.28 - $2.85 $1.37 Million - $3.04 Million	1,066,426 Added 23.94%	5,520,453 $11.3 Million
Q4 2023 Feb 13, 2024	BUY	$1.28 - $2.85 $4.81 Million - $10.7 Million	3,758,212 Added 213.26%	5,520,453 $11.3 Million
Q3 2023 Nov 15, 2023	SELL	$1.19 - $2.26 $18,070 - $34,318	-15,185 Reduced 0.85%	1,762,241 $3.03 Million
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.03 $91,630 - $167,252	-55,199 Reduced 3.01%	1,777,426 $3.47 Million
Q1 2023 May 15, 2023	SELL	$2.13 - $3.74 $340,489 - $597,853	-159,854 Reduced 8.02%	1,832,625 $5.09 Million
Q4 2022 Feb 14, 2023	SELL	$2.17 - $3.92 $138,506 - $250,205	-63,828 Reduced 3.1%	1,992,479 $6.87 Million
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $1.89 Million - $3.65 Million	768,500 Added 59.68%	2,056,307 $5.29 Million
Q2 2022 Oct 27, 2022	BUY	$1.77 - $4.34 $1.94 Million - $4.75 Million	1,093,446 Added 562.59%	1,287,807 $3.12 Million
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $1.94 Million - $4.75 Million	1,093,446 Added 562.59%	1,287,807 $3.12 Million
Q1 2022 Oct 27, 2022	SELL	$4.03 - $12.19 $4.41 Million - $13.3 Million	-1,093,446 Reduced 84.91%	194,361 $801,000
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $646,045 - $1.95 Million	160,309 Added 470.78%	194,361 $801,000
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $68,231 - $106,787	-7,789 Reduced 18.62%	34,052 $437,000
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $268,200 - $566,527	41,841 New	41,841 $451,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account